Recommend high CBD, low THC products to marijuana-using patients with psychosisNovember 4, 2017Schizophrenia & Other Psychotic Disorders
New BACE1 study launches in the shadow of verubecestat’s demiseNovember 4, 2017Alzheimer's & CognitionNeurologyGeriatrics
Aducanumab continues to rack up positive numbers in phase 1b open-label extensionNovember 3, 2017Alzheimer's & CognitionGeriatricsNeurology
In Lewy body disease, CSF may reveal dementia riskNovember 3, 2017Alzheimer's & CognitionMovement Disorders
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentumNovember 2, 2017Alzheimer's & CognitionGeriatricsNeurology
Guselkumab tops adalimumab for psychiatric comorbidities in psoriasisOctober 31, 2017Anxiety DisordersDepression
Rethinking lithium: It keeps patients with unipolar depression out of the hospitalOctober 29, 2017Depression
Lumateperone shows broad phase 3 potential for psychiatric disordersOctober 29, 2017Schizophrenia & Other Psychotic DisordersBipolar DisorderAlzheimer's & Cognition
Psoriasis patients face higher risk of alcohol-related death – but lower suicide riskOctober 27, 2017DepressionAddiction Medicine
